Viewing Study NCT00885066


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-01-01 @ 4:10 PM
Study NCT ID: NCT00885066
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2009-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Sponsor: Centre Antoine Lacassagne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module